Meconium ileus in patients with cystic fibrosis is not a risk factor for clinical deterioration and survival: The israeli multicenter study

Journal of Pediatric Gastroenterology and Nutrition

Volumn 50, Issue 2, 2010, Pages 173-178

  Efrati, Ori ^a   Nir, Judith ^b   Fraser, Drora ^c   Cohen Cymberknoh, Malena ^c   Shoseyov, David ^c   Vilozni, Daphna ^a   Modan Moses, Dalit ^a   Levy, Ran ^a   Szeinberg, Amir ^a   Kerem, Eitan ^c   Rivlin, Joseph ^d  

^a Safra Children's Hospital   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d CARMEL MEDICAL CENTER   (Israel)

Author keywords

Cystic fibrosis; Meconium ileus; Nutritional status; Pulmonary function; Survival

Indexed keywords

DIATRIZOATE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BODY MASS; CYSTIC FIBROSIS; DETERIORATION; EDEMA; FEMALE; FOLLOW UP; HUMAN; ISRAEL; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MECONIUM ILEUS; NUTRITIONAL STATUS; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE;

ADOLESCENT; ADULT; AGE FACTORS; BODY MASS INDEX; CHILD; CYSTIC FIBROSIS; DIATRIZOATE MEGLUMINE; DISEASE PROGRESSION; ENEMA; FEMALE; HUMANS; ILEUS; INFANT; ISRAEL; LUNG; MALE; MECONIUM; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

BACTERIA (MICROORGANISMS);

EID: 76349088287     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181a3bfdd     Document Type: Article

References (26)

1. Cystic Fibrosis Foundation. Patient Registry 2000 Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation; 2001.
2. Munck A, Gerardin M, Alberti C, et al. Clinical outcome of cystic fibrosis presenting with or without meconium ileus: a matched cohort study. J Pediatr Surg 2006;41:1556-1560
3. Evans AK, Fitzgerald DA, McKay KO. The impact of meconium ileus on the clinical course of children with cystic fibrosis. Eur Respir J 2001;18:784-789
4. Fuchs JR, Langer JC. Long-term outcome after neonatal meconium obstruction. Pediatrics 1998;101:E7.
5. Caniano DA, Beaver BL. Meconium ileus: a fifteen-year experience with forty-two neonates. Surgery 1987;102:699-703.
6. Lai HJ, Cheng Y, Cho H, et al. Association between initial disease presentation, lung disease outcomes, and survival in patients with cystic fibrosis. Am J Epidemiol 2004;159:537-546
7. Farrell PM, Kosorok MR, Rock MJ, et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics 2001;107:1-13.
8. Waters DL, Wilcken B, Irwing L, et al. Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed 1999; 80:F1-7. (Pubitemid 29129589)
9. Merelle ME, Schouten JP, Gerritsen J, et al. Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients. Eur Respir J 2001;18:306-315
10. Assael BM, Castellani C, Ocampo MB, et al. Epidemiology and survival analysis of cystic fibrosis in an area of intense neonatal screening over 30 years. Am J Epidemiol 2002;156:397-401.
11. Lai HC, Kosorok MR, Laxova A, et al. Nutritional status of patients with cystic fibrosis with meconium ileus: a comparison with patients without meconium ileus and diagnosed early through neonatal screening. Pediatrics 2000;105:53-61.
12. Li Z, Lai HJ, Kosorok MR, et al. Longitudinal pulmonary status of cystic fibrosis children with meconium ileus. Pediatr Pulmonol 2004;38:277-284
13. Mornet E, Simon-Bouy B, Serre JL, et al. Genetic differences between cystic fibrosis with and without meconium ileus. Lancet 1988;1:376-378
14. Allan JL, Robbie M, Phelan PD, et al. Familial occurrence of meconium ileus. Eur J Pediatr 1981;135:291-292
15. Hamill PV, Drizd TA, Johnson CL, et al. Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr 1979;32:607-629
16. Dibley MJ, Goldsby JB, Staehling NW, et al. Development of normalized curves for the international growth reference: historical and technical considerations. Am J Clin Nutr 1987;46:736-748
17. Dibley MJ, Staehling N, Nieburg P, et al. Interpretation of Z-score anthropometric indicators derived from the international growth reference. Am J Clin Nutr 1987;46:749-762
18. Hudson I, Phelan PD. Are sex, age at diagnosis, or mode of presentation prognostic factors for cystic fibrosis? Pediatr Pulmonol 1987;3: 288-297
19. Farrell PM, Kosorok MR, Laxova A, et al. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. N Engl J Med 1997;337:963-969
20. Dray X, Bienvenu T, Desmazes-Dufeu N, et al. Distal intestinal obstruction syndrome in adults with cystic fibrosis. Clin Gastroenterol Hepatol 2004;2:498-503.
21. Hamosh A, King TM, Rosenstein BJ, et al. Cystic fibrosis patients bearing both the common missense mutation Gly-Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileus. Am J Hum Genet 1992;51:245-250
22. Correlation between genotype and phenotype in patients with cystic fibrosis. The Cystic Fibrosis Genotype-Phenotype Consortium. N Engl J Med 1993; 329:1308-1313.
23. Abeliovich D, Lavon IP, Lerer I, et al. Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population. Am J Hum Genet 1992;51:951-956
24. Zielenski J, Corey M, Rozmahel R, et al. Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nat Genet 1999;22:128-129
25. RescorlaFJ,GrosfeldJL,WestKJ, et al.Changingpatternsoftreatmentand survival in neonates with meconium ileus. Arch Surg 1989;124:837-840
26. Del Pin CA, Czyrko C, Ziegler MM, et al. Management and survival of meconium ileus. A 30-year review. Ann Surg 1992;215:179-185